Cell Death Discovery,
Journal Year:
2023,
Volume and Issue:
9(1)
Published: May 10, 2023
Stroke
has
caused
tremendous
social
stress
worldwide,
yet
despite
decades
of
research
and
development
new
stroke
drugs,
most
have
failed
rt-PA
(Recombinant
tissue
plasminogen
activator)
is
still
the
accepted
treatment
for
ischemic
stroke.
complexity
mechanism
led
to
unsatisfactory
efficacy
drugs
in
clinical
trials,
indicating
that
there
are
many
gaps
our
understanding
Pyroptosis
a
programmed
cell
death
(PCD)
with
inflammatory
properties
thought
be
closely
associated
regulated
by
GSDMD
gasdermin
family,
which
when
cleaved
Caspase-1/Caspase-11
into
N-GSDMD
pore-forming
activity
can
bind
plasma
membrane
form
small
10-20
nm
pores,
would
allow
release
factors
IL-18
IL-1β
before
rupture,
greatly
exacerbating
response.
The
pyroptosis
occurs
mainly
border
zone
cerebral
infarction,
glial
cells,
neuronal
cells
brain
microvascular
endothelial
(BMECs)
all
undergo
after
stroke,
largely
exacerbates
breakdown
blood-brain
barrier
(BBB)
thus
aggravates
injury.
Therefore,
may
good
direction
In
this
review,
we
focus
on
latest
mechanisms
action
process
regulates
development.
We
also
suggest
potential
therapeutic
target
pathway,
providing
additional
strategies
management
role
After
microglia
first
rush
damaged
area
polarize
M1
M2
types.
Under
influence
various
stimuli,
pyroptosis,
pro-inflammatory
factors,
converted
type;
astrocytes
under
stimulation
leading
astrocyte
due
increased
osmotic
pressure
membrane,
resulting
water
absorption
swelling
until
rupture.
BMECs,
main
structural
component
BBB,
stimulated
released
from
astrocytes,
destruction
integrity
ultimately
causing
more
severe
damage.
addition,
neutrophils
mediate
NETs
rather
than
IL-10=interleukin-10;
TGF-β
=
transforming
growth
factor-β;
IL-18=interleukin-18;
interleukin-1β;
TNF-α
tumor
necrosis
factor-α;
iNOS=induced
nitrogen
monoxide
synthase;
MMPs=Matrix
metalloproteinases;
D;
BMECs=brain
cells;
BBB
barrier.
Genes & Diseases,
Journal Year:
2022,
Volume and Issue:
10(4), P. 1367 - 1401
Published: March 18, 2022
Cancer
is
an
abnormal
state
of
cells
where
they
undergo
uncontrolled
proliferation
and
produce
aggressive
malignancies
that
causes
millions
deaths
every
year.
With
the
new
understanding
molecular
mechanism(s)
disease
progression,
our
knowledge
about
snowballing,
leading
to
evolution
many
therapeutic
regimes
their
successive
trials.
In
past
few
decades,
various
combinations
therapies
have
been
proposed
are
presently
employed
in
treatment
diverse
cancers.
Targeted
drug
therapy,
immunotherapy,
personalized
medicines
now
largely
being
employed,
which
were
not
common
a
years
back.
The
field
cancer
discoveries
therapeutics
evolving
fast
as
type-specific
biomarkers
progressively
identified
several
types
cancers
nowadays
undergoing
systematic
therapies,
extending
patients'
disease-free
survival
thereafter.
Although
growing
evidence
shows
targeted
approach
could
be
future
medicine,
chemotherapy
remains
opted
option
despite
its
known
side
effects
on
patient's
physical
psychological
health.
Chemotherapeutic
agents/pharmaceuticals
served
great
purpose
over
decades
remained
frontline
choice
for
advanced-stage
surgery
and/or
radiation
therapy
cannot
prescribed
due
specific
reasons.
present
report
succinctly
reviews
existing
contemporary
advancements
assesses
status
enrolled
drugs/pharmaceuticals;
it
also
comprehensively
discusses
emerging
role
specific/targeted
strategies
achieve
better
clinical
success/survival
rate
patients.
Cell Death and Differentiation,
Journal Year:
2021,
Volume and Issue:
28(7), P. 2029 - 2044
Published: June 7, 2021
Tightly
orchestrated
programmed
cell
death
(PCD)
signalling
events
occur
during
normal
neuronal
development
in
a
spatially
and
temporally
restricted
manner
to
establish
the
neural
architecture
shaping
CNS.
Abnormalities
PCD
cascades,
such
as
apoptosis,
necroptosis,
pyroptosis,
ferroptosis,
associated
with
autophagy
well
unprogrammed
necrosis
can
be
observed
pathogenesis
of
various
neurological
diseases.
These
deaths
activated
response
forms
cellular
stress
(exerted
by
intracellular
or
extracellular
stimuli)
inflammatory
processes.
Aberrant
activation
pathways
is
common
feature
neurodegenerative
diseases,
amyotrophic
lateral
sclerosis
(ALS),
Alzheimer's
disease,
Parkinson's
Huntington's
resulting
unwanted
loss
cells
function.
Conversely,
inactivation
thought
contribute
brain
cancers
impact
their
therapy.
For
many
diseases
current
treatment
strategies
have
only
modest
effect,
engendering
need
for
investigations
into
origins
these
With
displaying
aberrations
pathways,
it
appears
that
agents
either
inhibit
induce
may
critical
components
future
therapeutic
strategies.
The
therapies
will
guided
preclinical
studies
animal
models
faithfully
mimic
human
disease.
In
this
review,
we
briefly
describe
processes
roles
they
play
contributing
tumorigenesis
brain.
We
also
discuss
interplay
between
distinct
cascades
disease
pharmacological
targeting
key
players
progressed
through
clinical
trials.
Bone Research,
Journal Year:
2022,
Volume and Issue:
10(1)
Published: Sept. 20, 2022
Abstract
Osteoarthritis
(OA)
is
the
most
common
degenerative
joint
disease
that
causes
painful
swelling
and
permanent
damage
to
joints
in
body.
The
molecular
mechanisms
of
OA
are
currently
unknown.
a
heterogeneous
affects
entire
joint,
multiple
tissues
altered
during
development.
To
better
understand
pathological
OA,
new
approaches,
methods,
techniques
need
be
used
pathogenesis.
In
this
review,
we
first
focus
on
epigenetic
regulation
with
particular
DNA
methylation,
histone
modification,
microRNA
regulation,
followed
by
summary
several
key
mediators
OA-associated
pain.
We
then
introduce
innovative
have
been
will
continue
fields
pain,
such
as
CRISPR,
scRNA
sequencing,
lineage
tracing.
Next,
discuss
timely
updates
concerning
cell
death
pathology,
including
pyroptosis,
ferroptosis,
autophagy,
well
their
individual
roles
potential
targets
treating
OA.
Finally,
our
review
highlights
directions
role
synovial
lymphatic
system
An
improved
understanding
pathogenesis
aid
development
more
specific
effective
therapeutic
interventions
for
Experimental & Molecular Medicine,
Journal Year:
2022,
Volume and Issue:
54(2), P. 129 - 142
Published: Feb. 1, 2022
Abstract
Low
back
pain
(LBP)
is
a
major
musculoskeletal
disorder
and
the
socioeconomic
problem
with
high
prevalence
that
mainly
involves
intervertebral
disc
(IVD)
degeneration,
characterized
by
progressive
nucleus
pulposus
(NP)
cell
death
development
of
an
inflammatory
microenvironment
in
NP
tissue.
Excessively
accumulated
cytosolic
DNA
acts
as
damage-associated
molecular
pattern
(DAMP)
monitored
cGAS-STING
axis
to
trigger
immune
response
many
degenerative
diseases.
NLRP3
inflammasome-dependent
pyroptosis
type
programmed
promotes
chronic
tissue
degeneration.
However,
relationship
between
inflammasome-induced
pathogenesis
IVD
degeneration
remains
unclear.
Here,
we
used
magnetic
resonance
imaging
(MRI)
histopathology
demonstrate
cGAS,
STING,
are
associated
degree
Oxidative
stress
induced
activation
inflammasome-mediated
STING-dependent
manner
human
cells.
Interestingly,
canonical
morphological
functional
characteristics
mitochondrial
permeability
transition
pore
(mPTP)
opening
escape
(mtDNA)
were
observed
cells
under
oxidative
stress.
Furthermore,
administration
specific
pharmacological
inhibitor
mPTP
self-mtDNA
leakage
effectively
reduced
pyroptotic
microenvironmental
inflammation
vitro
progression
rat
needle
puncture
model.
Collectively,
these
data
highlight
critical
roles
cGAS-STING-NLRP3
provide
promising
therapeutic
approaches
for
discogenic
LBP.
Molecular Cancer,
Journal Year:
2022,
Volume and Issue:
21(1)
Published: Jan. 28, 2022
Abstract
N6-methyladenosine
(m6A)
methylation,
the
most
common
form
of
internal
RNA
modification
in
eukaryotes,
has
gained
increasing
attention
and
become
a
hot
research
topic
recent
years.
M6A
plays
multifunctional
roles
normal
abnormal
biological
processes,
its
role
may
vary
greatly
depending
on
position
m6A
motif.
Programmed
cell
death
(PCD)
includes
apoptosis,
autophagy,
pyroptosis,
necroptosis
ferroptosis,
which
involve
breakdown
plasma
membrane.
Based
implications
methylation
PCD,
regulators
functional
were
comprehensively
studied
reported.
In
this
review,
we
focus
high-complexity
links
between
different
types
PCD
pathways,
are
then
closely
associated
with
initiation,
progression
resistance
cancer.
Herein,
clarifying
relationship
is
great
significance
to
provide
novel
strategies
for
cancer
treatment,
potential
prospect
clinical
application.
Frontiers in Cell and Developmental Biology,
Journal Year:
2021,
Volume and Issue:
9
Published: June 11, 2021
Gastric
cancer
(GC)
is
one
of
the
leading
causes
cancer-related
deaths
and
shows
high
levels
heterogeneity.
The
development
a
specific
prognostic
model
important
if
we
are
to
improve
treatment
strategies.
Pyroptosis
can
arise
in
response
H.
pylori
,
primary
carcinogen,
also
chemotherapy
drugs.
However,
evaluation
GC
pyroptosis
insufficient.
Consensus
clustering
by
pyroptosis-related
regulators
was
used
classify
618
patients
with
from
four
GEO
cohorts.
Following
Cox
regression
differentially
expressed
genes,
our
prognosis
(PS-score)
built
LASSO-Cox
analysis.
TCGA-STAD
cohort
as
validation
set.
ESTIMATE,
CIBERSORTx,
EPIC
were
investigate
tumor
microenvironment
(TME).
Immunotherapy
cohorts
blocking
PD1
/
PD-L1
response.
subtyping
based
on
able
according
different
clinical
traits
TME.
difference
between
two
subtypes
identified
this
study
develop
which
named
“PS-score.”
PS-score
could
predict
his/her
overall
survival
time.
A
low
implies
greater
inflammatory
cell
infiltration
better
immunotherapy
blockers.
Our
findings
provide
foundation
for
future
research
targeting
its
immune
responses
immunotherapy.